Comorbidity and its impact in adult patients with attention-deficit/ hyperactivity disorder: A primary care perspective

Postgraduate Medicine

Volumn 121, Issue 3, 2009, Pages 73-82

  Babcock, Thomas ^a,b   Ornstein, Craig S ^a,b  

^a SHIRE   (United States)

^b Advogent   (United States)

Author keywords

Attention deficit hyperactivity disorder: Psychiatric comorbidity; Bipolar disorder; Conduct disorder; Major depressive disorder; Oppositional defiant disorder; Substance use disorder

Indexed keywords

ATOMOXETINE; DESIPRAMINE; METHYLPHENIDATE; PLACEBO; VALPROATE SEMISODIUM;

ALCOHOLISM; ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILDHOOD; CLINICAL TRIAL; COMORBIDITY; CONDUCT DISORDER; HEALTH STATUS; HUMAN; MAJOR DEPRESSION; OPPOSITIONAL DEFIANT DISORDER; PREVALENCE; PSYCHOLOGIC ASSESSMENT; RATING SCALE; REVIEW; RISK ASSESSMENT; SELF REPORT; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; TREATMENT RESPONSE; ADDICTION; ADULT; HEALTH; METHODOLOGY; PRIMARY HEALTH CARE; PSYCHOSIS;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; COMORBIDITY; CONDUCT DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; PRIMARY HEALTH CARE; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS; WORLD HEALTH;

EID: 67549102411     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.05.2005     Document Type: Review

References (58)

1. Kessler RC, Adler LA, Barkley R, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005;57(11):1442-1451. (Pubitemid 40798566)
2. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111(2):279-289. (Pubitemid 34441206)
3. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816-818. (Pubitemid 30249663)
4. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723. (Pubitemid 44464584)
5. Robison LM, Skaer TL, Sclar DA. Is attention-deficit hyperactivity disorder (ADHD) diagnosed in adults? An examination of US office-based physician visits, 1995 2000. Int J Pharm Med. 2004;18(6):337-341. (Pubitemid 41729111)
6. Adler LA. Issues in the treatment and diagnosis of adult attention deficit-hyperactivity disorder (ADHD) in adults by primary care physicians. Poster presented at: the Collegium Internationale Neuro-Psychopharmacologicum: July 9-13, 2006; Chicago, IL.
7. Donnelly CL, Reimherr FW, Young JL. Differential diagnosis and treatment of adult ADHD and neighboring disorders. CNS Spectr. 2006;11(10 suppl 11):1-14. (Pubitemid 44571908)
8. Culpepper L. Primary care treatment of attention-deficit/ hyperactivity disorder. J Clin Psychiatry. 2006;67(suppl 8):51-58. (Pubitemid 44385607)
9. Adler LA, Sitt DJ, Nierenberg A. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Poster presented at: American Academy of Child and Adolescent Psychiatry; October 27, 2006; San Diego, CA.
10. Wilens TE, Dodson W. A clinical perspective of attention-deficit/ hyperactivity disorder into adulthood. J Clin Psychiatry. 2004;65(10): 1301-1313.
11. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602 (Pubitemid 40973434)
12. Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006;36(2):167-179. (Pubitemid 43126141)
13. Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000;9(3):525-540, vii. (Pubitemid 30620542)
14. Braaten EB, Beiderman J, Monuteaux MC, et al. Revisiting the association between attention-deficit/hyperactivity disorder and anxiety disorders: a familial risk analysis. Biol Psychiatry. 2003;53(1):93-99. (Pubitemid 36050940)
15. Wilens TE, Biederman J, Wozniak J, Gunawardene S, Wong J, Monuteaux M. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry. 2003; 54(1):1-8. (Pubitemid 36776717)
16. Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol. 1996;6(3):165-175. (Pubitemid 26414050)
17. Fischer AG, Bau CH, Grevet EH, et al. The role of comorbid major depressive disorder in the clinical presentation of adult ADHD. J Psychiatr Res. 2007;41(12):991-996. (Pubitemid 47301943)
18. Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. Ambul Pediatr. 2007;7(suppl 1):73-81. (Pubitemid 46140757)
19. Loeber R, Burke JD, Lahey BB. What are adolescent antecedents to antisocial personality disorder? Crim Behav Ment Health. 2002;12(1)24-36.
20. Lahey BB, Loeber R, Burke JD, Applegate B. Predicting future antisocial personality disorder in males from a clinical assessment in childhood. J Consult Clin Psychol. 2005;73(3):389-399. (Pubitemid 40885089)
21. Moffitt TE. Juvenile delinquency and attention deficit disorder: boys developmental trajectories front age 3 to age 15. Child Dev. 1990;61(3):893-910.
22. Satterfield JH, Schell A. A prospective study of hyperactive boys with conduct problems and normal boys adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry. 1997;36(12):1726-1735. (Pubitemid 27512327)
23. Moffitt TE, Caspi A, Harrington H, Milne BJ. Males on the life-course-persistent and adolescence-limited antisocial pathways: follow-up at age 26 years. Dev Psychopathol. 2002;14(1):179-207. (Pubitemid 351690114)
24. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000;61(4):244-251. (Pubitemid 30305365)
25. Hovens JG, Cantwell DP, Kiriakos R. Psychiatric comorbidity in hospitalized adolescent substance abusers. J Am Acad Child Adolesc Psychiatry. 1994;33(4):476-483. (Pubitemid 24133066)
26. Busch B, Biederman J, Cohen LG, et al. Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatr Scrv. 2002;53(9):103-1111.
27. Montano B. Diagnosis and treatment of ADHD in adults in primary care. J Clin Psychiatry. 2004;65(suppl 3):18-21.
28. Wasserstein J. Diagnostic issues for adolescents and adults with ADHD. J Clin Psychol. 2005;61(5):535-547. (Pubitemid 40776542)
29. American Psychiatric Association. Diagnostic and Manual of Mental Disorders. Text Revision: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association: 2000.
30. Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187-201. (Pubitemid 38452762)
31. Adler L, Kessler R, Spencer T, Adult Self Report Scale. ASRS-VL1 Screener. New York, NY: World Health Organization; 2003.
32. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population Psychol Med. 2005;35(2):245-256.
33. Adler LA, Spencer T, Faraone SV, et al. Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry. 2006;18(3):145-148. (Pubitemid 44576434)
34. Rosler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256(suppl 1):i3-i11. (Pubitemid 44411283)
35. Barkley RA, Murphy KR. Attention-Deficit Hyperactivity Disorder. A Clinical Workbook. 2nd ed. New York, NY: Guilford; 1998.
36. Adler L, Spencer T, Biederman J. Adult ADHD Investigator, Symptom Rating Scale. New York. NY: New York University School of Medicine: 2003.
37. Conners CK, Erhardt D, Sparrow EP. Conners' Adult ADHD Rating Scales (CAARS) Technical Manual. North Tonawanda, NY: Multi-Health Systems Inc; 1999.
38. Wender PH. Attention-Deficit Hyperactivity Disorder, in Adults. Oxford, England: Oxford University Press; 1995.
39. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for Axis 1 DSM-IV Disorders-Patient Edition (With Psychotic Screen) (SCID-I/P) (Version 2.0). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1996.
40. Derogatis LR. Symptom Checklist-90 (Revised): Administration, Scoring, and Procedures Manual, II. Towson, MD: Clinical Psychometric Research; 1992.
41. Spencer TJ, Faraone SV, Michelson D, et al. Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. J Clin Psychiatry. 2006;67(3):415-420.
42. Spencer T, Biederman J, Wilens T, et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(5):456-463. (Pubitemid 40311979)
43. Riordan HJ, Flashnian LA, Saykin AJ, Frutiger SA, Carroll KE, Huey L. Neuropsychological correlates of methylphenidate treatment in adult ADHD with and without depression. Arch Clin Neuropsychol. 1999; 14(2):217-233. (Pubitemid 29108546)
44. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995;52(6):434-443.
45. Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153(9):1147-1153. (Pubitemid 26299833)
46. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40(2):147-158. (Pubitemid 32111018)
47. Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28(6):882-887. (Pubitemid 20031022)
48. Sobanski E. Psychiatric comorbidity in adults with attention-deficit/ hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256(suppl 1):i26-i31. (Pubitemid 44411277)
49. Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry. 1985;142(5):547-552. (Pubitemid 15034621)
50. Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2000;61(6): 414-417. (Pubitemid 30452207)
51. Adler LA, Reingold LS, Morrill MS, Wilens TE. Combination pharmacotherapy for adult ADHD. Curr Psychiatry Rep. 2006;8(5): 409-415. (Pubitemid 44515394)
52. Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol. 1993;3:1-10.
53. Myronuk LD, Weiss M, Cotter L. Combined treatment with moclobemide and methylphenidate for comorbid major depression and adult attention-deficit/ hyperactivity disorder. J Clin Psychopharmacol. 1996;16(6):468-469. (Pubitemid 26423320)
54. Scheffer RE, Kowatch RA, Carmody T, Rush AJ. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162(1):58-64. (Pubitemid 40095673)
55. Somoza EC, Winhusen TM, Bridge TP, et al. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J Addict Dis. 2004;23(1):77-92. (Pubitemid 38437637)
56. Levin FR, Evans SM, McDowell DM, Brooks DJ, Nunes E. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis. 2002;21(2):1-16. (Pubitemid 35205006)
57. Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescent. J Am Acad Child Adolesc Psychiatry. 2004;43(4)420-429. (Pubitemid 38812382)
58. Carpentier PJ, de Jong CA, Dijkstra BA, Verbrugge CA, Krabbe PF. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction. 2005:100(12):1868-1874. (Pubitemid 41775212)